The Patent Finder

Nephrogenex, Inc.

Also on record
Records under this name other than patents Nephrogenex, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Nephrogenex, Inc.

PatentTitleStatus Expires Confidence
US 9,428,533Inhibitors of Advanced Glycation End Products
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,214,799Methods for the Synthesis of Pyridoxamine
Formerly held
Term ended
Term ended Feb 9, 2025 · High confidence
Term endedTerm ended Feb 9, 2025High confidence
US 8,431,712Methods for the Synthesis of Pyridoxamine
Lapsed on the fee record
Ended Apr 30, 2021 · Medium confidence
Lapsed on the fee recordEnded Apr 30, 2021Medium confidence
US 8,067,444Pyridoxamine for the Treatment of Diabetic Intermediaries and Post-Amadori Inhibition
Lapsed on the fee record
Ended Nov 29, 2019 · Medium confidence
Lapsed on the fee recordEnded Nov 29, 2019Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited